DALENA CUSTER: Open Payments
NPI 1184706806 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,338 in 123 payments from 13 companies in 2025. Trend: 2023 $2,729 · 2024 $3,224 · 2025 $2,338
Food & beverage: $2,338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $376 |
| AstraZeneca Pharmaceuticals LP | 17 | $375 |
| Lilly USA, LLC | 17 | $320 |
| PFIZER INC. | 21 | $301 |
| Amgen Inc. | 11 | $262 |
| Novo Nordisk Inc | 17 | $234 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
Products named: NURTEC ODT, VRAYLAR, MOUNJARO, AIRSUPRA, FARXIGA, REPATHA, UBRELVY, Ozempic.
Industry payments across NC — which companies pay providers there.
